Brain-computer interfaces (BCIs) are rapidly evolving in medtech, advancing into clinical trials. Synchron, led by CEO Thomas Oxley, pioneers an endovascular BCI, avoiding open brain surgery. Backed by investors like Gates and Bezos, Synchron aims to restore autonomy for paralyzed patients. Inspired by interventional cardiology, Synchron's approach is shaping a new frontier in neurotechnology, merging biomedical innovation with real-world applications.
Predictable Winners: A Blueprint for Medtech Innovation That Actually Works
Most medtech innovations fail—but they don’t have to. In Predictable Winners, Ilya Trakhtenberg and Stuart Jackson of L.E.K. Consulting offer a proven, step-by-step framework to improve your odds. Drawing on decades of real-world experience, the authors reveal how medtech companies can systematically de-risk innovation, forecast smarter, execute better, and build enduring franchises. This isn’t theory—it’s a tactical guide for founders, operators, and leaders navigating a high-stakes landscape. From concept to commercialization and beyond, discover how to turn your breakthrough idea into a market-defining success story. Because success isn’t luck—it’s learnable.
Write a comment ...